Berberine, a golden-yellow isoquinoline alkaloid extracted from plants such as Berberis species, Coptis chinensis (goldthread), and Hydrastis canadensis (goldenseal), has been a cornerstone of traditional Chinese and Ayurvedic medicine for over 3,000 years. Today, it is one of the most extensively researched botanical compounds in modern science — with thousands of published studies validating its metabolic, cardiovascular, and antimicrobial benefits. However, the classic challenge with berberine has always been poor oral bioavailability. Enter Liposomal Berberine Hydrochloride — a breakthrough delivery technology that dramatically enhances absorption, making berberine's therapeutic potential truly accessible.
Berberine is a naturally occurring alkaloid found in several medicinal plants:
Berberis aristata (Indian Barberry / Tree Turmeric) — the primary commercial source, native to the Himalayan regions
Berberis vulgaris (European Barberry) — traditional European medicinal herb
Coptis chinensis (Chinese Goldthread / Huang Lian) — a key herb in traditional Chinese medicine
Hydrastis canadensis (Goldenseal) — native North American medicinal plant
Tinospora cordifolia (Guduchi) — Ayurvedic medicinal vine
Berberine Hydrochloride (C₂₀H₁₈ClNO₄) is the hydrochloride salt form of berberine, the most commercially available and well-studied berberine compound.
Property Details Chemical Name Berberine Hydrochloride Molecular Formula C₂₀H₁₈ClNO₄ Molecular Weight 371.82 g/mol CAS Number 633-65-8 Appearance Yellow crystalline powder
Standard berberine HCl suffers from notoriously poor oral bioavailability due to:
Low intestinal absorption — berberine is a P-glycoprotein substrate, leading to active efflux from intestinal cells
Extensive first-pass metabolism — rapid hepatic metabolism reduces systemic exposure
Poor aqueous solubility — limits dissolution in the gastrointestinal tract
Reported oral bioavailability of standard berberine HCl is typically less than 1%.
Liposomal encapsulation addresses these challenges by:
Encapsulating berberine HCl within phospholipid bilayer vesicles (liposomes)
Protecting the active from gastric degradation and P-glycoprotein efflux
Enhancing intestinal absorption via liposome-mediated cellular uptake (endocytosis and membrane fusion)
Improving sustained release — liposomes provide controlled release profiles
Our liposomal berberine HCl achieves standardized 40% berberine content within the liposomal matrix, representing a significant advancement over conventional berberine supplements.
Specification Details Product Name Liposomal Berberine Hydrochloride Berberine Content 40% (liposomal encapsulated) Lipid Composition Phosphatidylcholine (soy/sunflower-derived) Particle Size 100–200 nm (DLS measured) Encapsulation Efficiency ≥ 85% Appearance Yellow to brownish powder or dispersion Assay Method HPLC Shelf Life 24 months (sealed, cool, dry storage)
Each batch includes:
Berberine HCl content (HPLC)
Liposome particle size distribution
Encapsulation efficiency
Heavy metals analysis
Microbiological testing
Residual solvent testing
Berberine's most celebrated and well-documented benefit is its powerful effect on glucose metabolism:
AMPK activation: Berberine activates AMP-activated protein kinase (AMPK), often called the "metabolic master switch," improving insulin sensitivity and glucose uptake
GLUT4 upregulation: Increases translocation of GLUT4 glucose transporters to cell membranes
Hepatic gluconeogenesis inhibition: Reduces excessive glucose production by the liver
Comparable efficacy to metformin: Multiple clinical trials have shown berberine's glucose-lowering effects to be comparable to first-line pharmaceutical metformin
Reference: Yin, J., Gao, Z., Liu, D., Liu, Z., & Ye, J. (2008). Berberine improves glucose metabolism through induction of glycolysis. American Journal of Physiology - Endocrinology and Metabolism, 294(1), E148–E156.
Reference: Zhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., ... & Ning, G. (2008). Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. Journal of Clinical Endocrinology & Metabolism, 93(7), 2559–2565.
Berberine has demonstrated comprehensive cardiovascular benefits:
LDL receptor upregulation: Berberine increases LDL receptor expression via a post-transcriptional mechanism distinct from statins, effectively lowering circulating LDL cholesterol
Triglyceride reduction: Inhibits hepatic lipogenesis and enhances fatty acid oxidation
Blood pressure support: Promotes endothelial nitric oxide (NO) production, improving vasodilation
Anti-arrhythmic properties: Modulates cardiac ion channels
Reference: Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., ... & Jiang, J. D. (2004). Berberine is a novel cholesterol-lowering compound working through a unique mechanism distinct from statins. Nature Medicine, 10(12), 1344–1351.
Emerging research highlights berberine as a powerful gut microbiome modulator:
Selective antimicrobial activity: Targets pathogenic bacteria (e.g., E. coli, H. pylori) while sparing beneficial commensals
Microbiome diversity enhancement: Increases abundance of Akkermansia muciniphila and other beneficial taxa associated with metabolic health
Intestinal barrier strengthening: Upregulates tight junction proteins, reducing intestinal permeability ("leaky gut")
Reference: Wang, Y., Shou, J. W., Li, X. Y., Zhao, X. Y., He, F., Ma, C., ... & Wang, Y. (2020). Berberine-induced biosynthesis of tertiary bile acids and its implications for metabolic disorders. Acta Pharmaceutica Sinica B, 10(3), 493–504.
NF-κB pathway inhibition: Berberine suppresses the nuclear factor kappa-light-chain-enhancer of activated B cells pathway, reducing expression of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β)
Macrophage polarization: Promotes shift from pro-inflammatory M1 to anti-inflammatory M2 macrophage phenotype
TLR4 signaling modulation: Downregulates Toll-like receptor 4 expression, reducing inflammatory cascades
Reference: Jeong, H. W., Hsu, K. C., Jeong, J. W., Ham, M., Lee, S. Y., Jung, H. J., ... & Kim, J. B. (2009). Berberine improves insulin resistance by mediating gut microbiota composition and reducing inflammatory cytokines. Metabolism, 58(11), 1506–1515.
Berberine has broad-spectrum antimicrobial activity:
Antibacterial: Effective against Staphylococcus aureus, Helicobacter pylori, and other Gram-positive bacteria
Antifungal: Activity against Candida albicans and other fungal pathogens
Antiviral: Shown activity against influenza virus, respiratory syncytial virus (RSV), and emerging viral targets
The liposomal formulation specifically addresses berberine's bioavailability limitations:
Enhanced absorption: Liposomes protect berberine from P-gp efflux and first-pass metabolism
Targeted delivery: Phospholipid vesicles can facilitate transport across intestinal epithelium via transcellular pathways
Sustained release: Controlled release profile maintains therapeutic concentrations over extended periods
Reduced gastrointestinal irritation: Encapsulation minimizes direct GI mucosal contact, reducing common side effects (nausea, cramping)
Reference: Li, C., et al. (2020). Liposomal berberine nanoparticles: A novel approach to improve oral bioavailability and therapeutic efficacy. International Journal of Pharmaceutics, 585, 119506.
Capsules and tablets: Standard berberine dosing ranges from 500–1500 mg/day (standard) vs. lower effective doses with liposomal formulation
Liquid formulations: Liposomal dispersions for direct oral use
Combination formulas: Paired with chromium, cinnamon extract, alpha-lipoic acid, or milk thistle for comprehensive metabolic support
Target markets: Blood sugar management, cardiovascular health, weight management, gut health
Metabolic health drinks: Liposomal berberine can be incorporated into functional beverages due to improved water dispersibility
Health shots: Concentrated wellness shots targeting metabolic wellness
Meal replacement shakes: Integrated into weight management and diabetic-friendly nutrition products
Investigational drug: Berberine is under active investigation for multiple therapeutic indications
Adjuvant therapy: Studied as an adjunct to standard diabetes medications
Gastrointestinal therapeutics: H. pylori eradication protocols and IBS management
Companion animal supplements: Metabolic and digestive health support for dogs and cats
Aquaculture: Antimicrobial and growth-promoting applications in fish farming (antibiotic alternative)
Livestock feed: Natural growth promoter and gut health enhancer
When evaluating a liposomal berberine supplier, consider these critical factors:
Liposome type: Phosphatidylcholine-based liposomes are the industry standard; sunflower-derived PC is preferred for allergen-free formulations
Particle size: Optimal range is 100–200 nm for efficient intestinal absorption — verified by dynamic light scattering (DLS)
Encapsulation efficiency: Should be ≥ 80% to ensure the majority of berberine is actually encapsulated
Botanical origin: Berberis aristata root extract is the most common and sustainable source
Purity: Berberine HCl should be ≥ 97% pure before encapsulation
Heavy metal control: Strict limits on Pb, As, Cd, Hg — particularly important for botanical extracts
Liposomal formulations are inherently more susceptible to degradation than standard powders
Suppliers should provide stability data (accelerated and real-time)
Proper packaging (nitrogen-flushed, moisture-barrier) is essential
Look for suppliers with:
HPLC-verified berberine content on every batch
Liposome characterization data (particle size, PDI, encapsulation efficiency)
ISO 22000 / HACCP / FSSC 22000 certifications
Kosher and Halal certifications
Full COA documentation including microbiological and heavy metal testing
Ability to adjust berberine concentration within the liposomal matrix
Custom carrier oil or phospholipid sources
Tailored particle size specifications for specific applications
As an experienced supplier specializing in advanced botanical extracts and novel delivery technologies, we are proud to offer our Liposomal Berberine Hydrochloride (40%) — combining the millennia-proven benefits of berberine with cutting-edge liposomal encapsulation technology.
Why choose our Liposomal Berberine HCl:
Advanced encapsulation: Proprietary liposomal technology delivering ≥ 85% encapsulation efficiency with optimal 100–200 nm particle size
Premium raw materials: Sourced from high-purity Berberis aristata root extract (≥ 97% berberine HCl)
Comprehensive testing: Every batch tested for berberine content, liposome characterization, heavy metals, and microbiological safety
Regulatory-ready documentation: Complete COA, stability data, and regulatory support for global market registration
Customization: Flexible formulation options including adjusted concentrations, alternative phospholipid sources, and tailored particle sizes
Technical partnership: Our R&D team provides application guidance, formulation support, and co-development opportunities
Liposomal Berberine Hydrochloride represents the next evolution in one of nature's most powerful and well-researched botanical compounds. By solving berberine's longstanding bioavailability challenge, liposomal technology unlocks its full therapeutic potential — from metabolic and cardiovascular health to gut microbiome modulation and beyond.
Looking to formulate with Liposomal Berberine Hydrochloride?
Contact us today for competitive pricing, free samples, and comprehensive technical documentation.
Our experienced team provides:
Custom liposomal formulations tailored to your application
Full regulatory and compliance documentation for global markets
Reliable, scalable supply with consistent quality
Dedicated technical support and formulation assistance
Stay ahead of the metabolic health trend — partner with us for premium Liposomal Berberine Hydrochloride that delivers real results.
2026-08-14
2026-08-14
2026-08-14
2026-08-14
2026-08-14
2026-08-14
2026-08-14
2026-08-14
2026-08-14
2026-08-14